Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial.

The Suppression of Ovarian Function trial showed improved disease control for tamoxifen plus ovarian function suppression (OFS) compared with tamoxifen alone for the cohort of premenopausal patients who received prior chemotherapy. We present the patient-reported outcomes.

Luo, Weixiu (author)
Bernhard, Jürg (author)
Francis, Prudence A (author)
Burstein, Harold J (author)
Ciruelos, Eva (author)
Bellet, Meritxell (author)
Pavesi, Lorenzo (author)
Lluch, Ana (author)
Visini, Marilena (author)
Parmar, Vani (author)
Tondini, Carlo (author)
Kerbrat, Pierre (author)
Perelló, Antonia (author)
Neven, Patrick (author)
Torres, Roberto (author)
Lombardi, Davide (author)
Puglisi, Fabio (author)
Karlsson, Per,1963Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för onkologi,Institute of Clinical Sciences, Department of Oncology(Swepub:gu)xkperd (author)
Ruhstaller, Thomas (author)
Colleoni, Marco (author)
Coates, Alan S (author)
Goldhirsch, Aron (author)
Price, Karen N (author)
Gelber, Richard D (author)
Regan, Meredith M (author)
Fleming, Gini F (author)
Göteborgs universitetInstitutionen för kliniska vetenskaper, Avdelningen för onkologi (creator_code:org_t)

In:Journal of clinical oncology : official journal of the American Society of Clinical Oncology34:14, s. 1601-16101527-7755

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Cancer and Oncol ...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.